文献速递男科与性医学

低强度冲击波治疗勃起功能障碍:Cochrane 综述简版

Low-intensity shockwave therapy for erectile dysfunction: An abridged Cochrane review.
PubMed 文献 · BJU Int · 2026-03-30

基于 2025 年 Cochrane 系统综述(CD013166),纳入 21 项 RCT(1357 例 39–65 岁男性)比较低强度冲击波治疗与假治疗对勃起功能障碍的疗效与安全性。LiSWT 可能轻度改善短期和长期勃起功能及短期阴茎硬度,对中断治疗和不良事件影响很小;证据确定性低。

要点

  • LiSWT 可能轻度改善短期勃起功能(MD 3.89,95%CI 2.89–4.89,低确定性)。
  • LiSWT 可能改善长期勃起功能(MD 5.25,95%CI 2.47–8.04,低确定性)。
  • LiSWT 对中断治疗和不良事件影响很小,满意度与生活质量无数据。

核心结论

  • 低强度冲击波治疗可能改善长期勃起功能和短期阴茎硬度,对中断治疗或不良事件影响很小,但证据确定性低。

研究设计与样本

  • 基于 Cochrane 系统综述 2025 年第 7 期(CD013166)的简版,纳入比较 LiSWT 与假治疗的随机对照试验,排除心理性或医源性 ED、肾移植或根治性前列腺切除术后患者。
  • 共分析 21 项 RCT,1357 名男性,年龄 39–65 岁。

主要发现

  • 短期勃起功能可能轻度改善:MD 3.89,95%CI 2.89–4.89;I²=62%;15 项研究;低确定性,临床重要性不确定。
  • 长期勃起功能可能改善:MD 5.25,95%CI 2.47–8.04;I²=87%;5 项研究;低确定性。
  • 中断治疗风险比 0.77,95%CI 0.47–1.27;I²=0%;不良事件风险差 0.00,95%CI -0.01–0.02;I²=0%。
  • 短期阴茎硬度可能改善:MD 1.06,95%CI 0.83–1.28;I²=53%;低确定性。
  • 满意度和生活质量数据不可用。

临床怎么用

  • 可用于向 ED 患者说明 LiSWT 可能轻度改善勃起功能和硬度,但对中断治疗和不良事件影响很小,且证据确定性低。
  • 临床决策需结合患者偏好和低确定性证据,不推荐作为唯一或首选治疗。

局限性

  • 证据确定性低,主要因方法学局限和异质性(如 I²=62%、87%)。
  • 满意度和生活质量数据不可用。
  • 排除心理性或医源性 ED、肾移植或根治性前列腺切除术后患者,适用人群受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the efficacy and safety of low-intensity shockwave therapy (LiSWT) for treating erectile dysfunction (ED) compared to sham therapy. METHODS: This summary is based on the Cochrane systematic review published in the Cochrane Database of Systematic Reviews 2025, Issue 7 (CD013166). We included randomised controlled trials (RCTs) comparing LiSWT to sham therapy. We excluded psychogenic or iatrogenic ED, kidney transplants, or radical prostatectomy. Critical outcomes were erectile function, discontinuation, and adverse events; important outcomes included rigidity, satisfaction, and quality of life. Certainty was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. RESULTS: A total of 21 RCTs (1357 men, aged 39-65 years) were analysed. LiSWT may slightly improve short-term erectile function (mean difference [MD] 3.89, 95% confidence interval [CI] 2.89-4.89; I2 = 62%; 15 studies; low-certainty), though clinical importance is uncertain. Long-term function may improve (MD 5.25, 95% CI 2.47-8.04; I2 = 87%; five studies; low-certainty). LiSWT likely has little effect on discontinuation (risk ratio 0.77, 95% CI 0.47-1.27; I2 = 0%) or adverse events (risk difference 0.00, 95% CI -0.01 to 0.02; I2 = 0%). It may improve short-term penile rigidity (MD 1.06, 95% CI 0.83-1.28; I2 = 53%; low-certainty). Data for satisfaction or quality of life were unavailable. CONCLUSIONS: Low-intensity shockwave therapy may improve long-term erectile function and short-term rigidity, with little difference in discontinuation or adverse events. Evidence certainty is low due to methodological limitations and heterogeneity.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Ergun O, Kim K, Kim MH, et al. Low-intensity shockwave therapy for erectile dysfunction: An abridged Cochrane review. BJU Int. 2026. PMID: 41906634. doi:10.1111/bju.70236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。